Antenatal diagnosis of hemoglobinopathies: social and technical considerations.
D000328:Adult; D000755:Anemia, Sickle Cell / Q000175:diagnosis; D002852:Chromatography, Ion Exchange; D004592:Electrophoresis, Starch Gel; D004912:Erythrocytes / Q000378:metabolism; D005260:Female; D005312:Fetal Blood; D005319:Fetal Hemoglobin / Q000096:biosynthesis; D005332:Fetoscopy; D005333:Fetus; D005865:Gestational Age; D006453:Hemoglobinopathies / Q000175:diagnosis*; D006454:Hemoglobins / Q000096:biosynthesis; D006455:Hemoglobins, Abnormal; D006720:Homozygote; D006801:Humans; D007231:Infant, Newborn; D007883:Legislation, Medical; D010446:Peptide Fragments / Q000096:biosynthesis; D010920:Placenta / Q000473:pathology; D011247:Pregnancy; D013789:Thalassemia / Q000175:diagnosis; D014314:Trisomy; D014481:United States
D006454:Hemoglobins; D006455:Hemoglobins, Abnormal; D010446:Peptide Fragments; D005319:Fetal Hemoglobin